-
Loading metrics
Open Access
Peer-reviewed
Research Article
Von Hippel-Lindau (VHL) Inactivation in Sporadic Clear Cell Renal Cancer: Associations with Germline VHL Polymorphisms and Etiologic Risk Factors
-
Lee E. Moore ,
* E-mail: moorele@mail.nih.gov
Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Michael L. Nickerson,
Affiliation Cancer and Inflammation Program, National Cancer Institute, Frederick, Maryland, United States of America
⨯ -
Paul Brennan,
Affiliation International Agency for Research on Cancer, Lyon, France
⨯ -
Jorge R. Toro,
Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Erich Jaeger,
Affiliation University of California San Francisco, San Francisco, California, United States of America
⨯ -
Jessica Rinsky,
Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Summer S. Han,
Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
David Zaridze,
Affiliation Institute of Carcinogenesis, Cancer Research Centre, Moscow, Russia
⨯ -
Vsevolod Matveev,
Affiliation Institute of Carcinogenesis, Cancer Research Centre, Moscow, Russia
⨯ -
Vladimir Janout,
Affiliation Department of Preventive Medicine, Faculty of Medicine, Palacky University, Olomouc, Czech Republic
⨯ -
Hellena Kollarova,
Affiliation Department of Preventive Medicine, Faculty of Medicine, Palacky University, Olomouc, Czech Republic
⨯ -
Vladimir Bencko,
Affiliation Institute of Hygiene and Epidemiology, Charles University, Prague, Czech Republic
⨯ -
Marie Navratilova,
Affiliation Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic
⨯ -
Neonilia Szeszenia-Dabrowska,
Affiliation Department of Epidemiology, Institute of Occupational Medicine, Lodz, Poland
⨯ -
Dana Mates,
Affiliation Institute of Public Health, Bucharest, Romania
⨯ -
Laura S. Schmidt,
Affiliations Basic Science Program, SAIC–Frederick, NCI–Frederick, Frederick, Maryland, United States of America, Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Petra Lenz,
Affiliation Support to the Division of Cancer Epidemiology and Genetics, National Cancer Institute, SAIC-Frederick, NCI- Frederick, Frederick, Maryland, United States of America
⨯ -
Sara Karami,
Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
W. Marston Linehan,
Affiliation Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Maria Merino,
Affiliation Support to the Division of Cancer Epidemiology and Genetics, National Cancer Institute, SAIC-Frederick, NCI- Frederick, Frederick, Maryland, United States of America
⨯ -
Stephen Chanock,
Affiliations Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America, Core Genotyping Facility at the Advanced Technology Center of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America
⨯ -
Paolo Boffetta,
Affiliations Cancer and Inflammation Program, National Cancer Institute, Frederick, Maryland, United States of America, The Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York, United States of America, International Cancer Prevention Research Institute, Lyon, France
⨯ -
Wong-Ho Chow,
Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ -
Frederic M. Waldman,
Affiliation University of California San Francisco, San Francisco, California, United States of America
⨯ - [ ... ],
-
Nathaniel Rothman
Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
⨯ - [ view all ]
- [ view less ]
Von Hippel-Lindau (VHL) Inactivation in Sporadic Clear Cell Renal Cancer: Associations with Germline VHL Polymorphisms and Etiologic Risk Factors
- Lee E. Moore,
- Michael L. Nickerson,
- Paul Brennan,
- Jorge R. Toro,
- Erich Jaeger,
- Jessica Rinsky,
- Summer S. Han,
- David Zaridze,
- Vsevolod Matveev,
- Vladimir Janout
- Published: October 13, 2011
- https://doi.org/10.1371/journal.pgen.1002312